Search
for
Sort by
Research 241–270 of 777
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Alopecia Areata: Current and Emerging Therapies
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- The Burden of Alopecia Areata and Management with Baricitinib in the United Arab Emirates: A Narrative Review
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Parsing patterns: Emerging roles of tissue self-organization in health and disease
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- An Updated in the Management of Alopecia Areata
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1
- The Frontal Fibrosing Alopecia Treatment Dilemma
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- The JAK/STAT signaling pathway: from bench to clinic
- Alopecia Areata: Current Treatments and New Directions
- Alopecia Areata: An Updated Review for 2023
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report